BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 12447962)

  • 1. Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor.
    Gajewski JL; Ippoliti C; Ma Y; Champlin R
    Am J Hematol; 2002 Dec; 71(4):311-3. PubMed ID: 12447962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunogenetics and immunologic aspects of kidney and bone marrow transplantation].
    Buc M
    Vnitr Lek; 1993 Oct; 39(10):988-94. PubMed ID: 8236871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful second transplant from one-locus HLA-mismatched unrelated donor for graft rejection following initial transplant from another unrelated donor in a patient with chronic myelogenous leukemia].
    Tanaka M; Kanamori H; Kuwabara H; Yamaji S; Kamijo A; Taguchi J; Fujita H; Fujisawa S; Matsuzaki M; Mohri H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Aug; 42(8):656-8. PubMed ID: 11579507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell.
    Li CK; Shing MM; Chik KW; Lee V; Tsang KS; Yuen PM
    Pediatr Hematol Oncol; 2002 Jun; 19(4):267-71. PubMed ID: 12051594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study.
    Lee KH; Choi SJ; Lee JH; Kim S; Seol M; Lee YS; Kim WK; Lee JS; Lee JH
    Bone Marrow Transplant; 2004 Oct; 34(7):627-36. PubMed ID: 15300231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
    Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
    Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor bone marrow in laryngeal transplantation: results of a rat study.
    Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
    Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
    Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
    Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lenograstim administration to HLA-identical donor-recipient pairs to accelerate marrow recovery post-transplant.
    Atkinson K; Fay K; Nivison-Smith I; Downs K
    Bone Marrow Transplant; 1997 Jan; 19(1):15-21. PubMed ID: 9012926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case report.
    Wagner L; Lengyel L; Mikala G; Reményi P; Piros L; Csomor J; Fábry L; Tordai A; Langer RM; Masszi T
    Transplant Proc; 2013; 45(10):3705-7. PubMed ID: 24315003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hematopoietic stem-cell transplantation in aplastic anemia].
    Hernández-Rivera EG
    Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated rejection following transplantation from an HLA-identical sibling.
    Grafft CA; Cornell LD; Gloor JM; Cosio FG; Gandhi MJ; Dean PG; Stegall MD; Amer H
    Nephrol Dial Transplant; 2010 Jan; 25(1):307-10. PubMed ID: 19846396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High immunologic risk living donor kidney transplant using bortezomib in a novel induction regimen without acute antibody mediated rejection.
    Dunn TB; Borja-Cacho D; Chinnakotla S; Finger E; Tamayo G; Verghese P; Kim Y; Manivel C; Kandaswamy R; Matas A; Pruett T; Noreen H; Krefting P; Maurer D
    Clin Transpl; 2011; ():381-7. PubMed ID: 22755435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
    Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
    Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.